XML 129 R48.htm IDEA: XBRL DOCUMENT v3.20.1
Financial Instruments (Tables)
12 Months Ended
Dec. 31, 2019
Financial Instruments [Abstract]  
Schedule of financial assets
The fair values of the Company’s investments, recurring other long-term assets (liabilities) and fixed rate long-term debt are outlined below:
 
 
 
2019
 
 
Carrying amount
 
 
 Fair value
Asset (liability) (1) (2)
 
 
 

 
Level 1

 
Level 2

 
Level 3 (4) (5)

Investments (3)
 
 
$
490

 
$
490

 
$

 
$

Other long-term assets
 
 
$
942

 
$

 
$
290

 
$
652

Other long-term liabilities
 
 
$
(207
)
 
$

 
$
(112
)
 
$
(95
)
Fixed rate long-term debt (6) (7)
 
 
$
(14,110
)

$
(15,938
)
 
$

 
$

 
 
 
2018
 
 
Carrying amount
 
 
Fair value
Asset (liability) (1) (2)
 
 
 
 
Level 1

 
Level 2

 
Level 3 (4) (5)

Investments (3)
 
 
$
524

 
$
524

 
$

 
$

Other long-term assets
 
 
$
964

 
$

 
$
373

 
$
591

Other long-term liabilities
 
 
$
(135
)
 
$

 
$
(17
)
 
$
(118
)
Fixed rate long-term debt (6) (7)
 
 
$
(15,620
)

$
(15,952
)
 
$

 
$

(1)
Excludes financial assets and liabilities where the carrying amount approximates fair value due to the short-term nature of the asset or liability (cash and cash equivalents, accounts receivable, accounts payable and accrued liabilities, and purchase consideration payable).
(2)
There were no transfers between Level 1, 2 and 3 financial instruments.
(3)
The fair values of the investments are based on quoted market prices.
(4)
The fair value of the deferred purchase consideration included in other long-term liabilities is based on the present value of future cash payments.
(5)
The fair value of Redwater Partnership subordinated debt is based on the present value of future cash receipts.
(6)
The fair value of fixed rate long-term debt has been determined based on quoted market prices.
(7)
Includes the current portion of fixed rate long-term debt.
The carrying amounts of the Company’s financial instruments by category were as follows:
 
 
2019
Asset (liability)
 
Financial
 assets at
amortized cost

 
Fair value
 through
profit or loss

 
Derivatives
 used for
 hedging

 
Financial
 liabilities at
 amortized cost

 
Total

Accounts receivable
 
$
2,465

 
$

 
$

 
$

 
$
2,465

Investments
 

 
490

 

 

 
490

Other long-term assets
 
652

 

 
290

 

 
942

Accounts payable
 

 

 

 
(816
)
 
(816
)
Accrued liabilities
 

 

 

 
(2,611
)
 
(2,611
)
Other long-term liabilities (1)
 

 
(21
)
 
(91
)
 
(1,904
)
 
(2,016
)
Long-term debt (2)
 

 

 

 
(20,982
)
 
(20,982
)
 
 
$
3,117

 
$
469

 
$
199

 
$
(26,313
)
 
$
(22,528
)
 
 
2018
Asset (liability)
 
Financial
 assets at
amortized cost

 
Fair value
 through
profit or loss

 
Derivatives
 used for
 hedging

 
Financial
 liabilities at
 amortized cost

 
Total

Accounts receivable
 
$
1,148

 
$

 
$

 
$

 
$
1,148

Investments
 

 
524

 

 

 
524

Other long-term assets
 
591

 
12

 
361

 

 
964

Accounts payable
 

 

 

 
(779
)
 
(779
)
Accrued liabilities
 

 

 

 
(2,356
)
 
(2,356
)
Other long-term liabilities (1)
 

 
(17
)
 

 
(118
)
 
(135
)
Long-term debt (2)
 

 

 

 
(20,623
)
 
(20,623
)
 
 
$
1,739

 
$
519

 
$
361

 
$
(23,876
)
 
$
(21,257
)
(1)
Includes $1,809 million of lease liabilities (December 31, 2018 – $nil) and $95 million of deferred purchase consideration payable over the next four years (December 31, 2018 – $118 million).
(2)
Includes the current portion of long-term debt.
Schedule of financial liabilities
The fair values of the Company’s investments, recurring other long-term assets (liabilities) and fixed rate long-term debt are outlined below:
 
 
 
2019
 
 
Carrying amount
 
 
 Fair value
Asset (liability) (1) (2)
 
 
 

 
Level 1

 
Level 2

 
Level 3 (4) (5)

Investments (3)
 
 
$
490

 
$
490

 
$

 
$

Other long-term assets
 
 
$
942

 
$

 
$
290

 
$
652

Other long-term liabilities
 
 
$
(207
)
 
$

 
$
(112
)
 
$
(95
)
Fixed rate long-term debt (6) (7)
 
 
$
(14,110
)

$
(15,938
)
 
$

 
$

 
 
 
2018
 
 
Carrying amount
 
 
Fair value
Asset (liability) (1) (2)
 
 
 
 
Level 1

 
Level 2

 
Level 3 (4) (5)

Investments (3)
 
 
$
524

 
$
524

 
$

 
$

Other long-term assets
 
 
$
964

 
$

 
$
373

 
$
591

Other long-term liabilities
 
 
$
(135
)
 
$

 
$
(17
)
 
$
(118
)
Fixed rate long-term debt (6) (7)
 
 
$
(15,620
)

$
(15,952
)
 
$

 
$

(1)
Excludes financial assets and liabilities where the carrying amount approximates fair value due to the short-term nature of the asset or liability (cash and cash equivalents, accounts receivable, accounts payable and accrued liabilities, and purchase consideration payable).
(2)
There were no transfers between Level 1, 2 and 3 financial instruments.
(3)
The fair values of the investments are based on quoted market prices.
(4)
The fair value of the deferred purchase consideration included in other long-term liabilities is based on the present value of future cash payments.
(5)
The fair value of Redwater Partnership subordinated debt is based on the present value of future cash receipts.
(6)
The fair value of fixed rate long-term debt has been determined based on quoted market prices.
(7)
Includes the current portion of fixed rate long-term debt.
The carrying amounts of the Company’s financial instruments by category were as follows:
 
 
2019
Asset (liability)
 
Financial
 assets at
amortized cost

 
Fair value
 through
profit or loss

 
Derivatives
 used for
 hedging

 
Financial
 liabilities at
 amortized cost

 
Total

Accounts receivable
 
$
2,465

 
$

 
$

 
$

 
$
2,465

Investments
 

 
490

 

 

 
490

Other long-term assets
 
652

 

 
290

 

 
942

Accounts payable
 

 

 

 
(816
)
 
(816
)
Accrued liabilities
 

 

 

 
(2,611
)
 
(2,611
)
Other long-term liabilities (1)
 

 
(21
)
 
(91
)
 
(1,904
)
 
(2,016
)
Long-term debt (2)
 

 

 

 
(20,982
)
 
(20,982
)
 
 
$
3,117

 
$
469

 
$
199

 
$
(26,313
)
 
$
(22,528
)
 
 
2018
Asset (liability)
 
Financial
 assets at
amortized cost

 
Fair value
 through
profit or loss

 
Derivatives
 used for
 hedging

 
Financial
 liabilities at
 amortized cost

 
Total

Accounts receivable
 
$
1,148

 
$

 
$

 
$

 
$
1,148

Investments
 

 
524

 

 

 
524

Other long-term assets
 
591

 
12

 
361

 

 
964

Accounts payable
 

 

 

 
(779
)
 
(779
)
Accrued liabilities
 

 

 

 
(2,356
)
 
(2,356
)
Other long-term liabilities (1)
 

 
(17
)
 

 
(118
)
 
(135
)
Long-term debt (2)
 

 

 

 
(20,623
)
 
(20,623
)
 
 
$
1,739

 
$
519

 
$
361

 
$
(23,876
)
 
$
(21,257
)
(1)
Includes $1,809 million of lease liabilities (December 31, 2018 – $nil) and $95 million of deferred purchase consideration payable over the next four years (December 31, 2018 – $118 million).
(2)
Includes the current portion of long-term debt.
Schedule of information about financial instruments
The following provides a summary of the carrying amounts of derivative financial instruments held and a reconciliation to the Company’s consolidated balance sheets.
Asset (liability)
 
2019


2018

Derivatives held for trading
 
 

 
Foreign currency forward contracts
 
$
(10
)

$
8

Natural gas AECO basis swaps
 
(8
)
 
1

 Natural gas AECO fixed price swaps
 
(3
)
 
3

Crude oil WCS (1) differential swaps
 

 
(17
)
Cash flow hedges
 
 


 

Foreign currency forward contracts
 
(91
)

70

Cross currency swaps
 
290


291

 
 
$
178

 
$
356

 
 
 
 
 
Included within:
 
 

 
 

Current portion of other long-term assets
 
$
8


$
92

Current portion of other long-term liabilities
 
(112
)

(17
)
Other long-term assets
 
282


281

 
 
$
178

 
$
356


(1)
Western Canadian Select
The changes in estimated fair values of derivative financial instruments included in the risk management asset were recognized in the financial statements as follows:
Asset (liability)
 
2019


2018

Balance – beginning of year
 
$
356


$
101

Net change in fair value of outstanding derivative financial instruments
recognized in:
 
 


 

Risk management activities
 
(13
)

35

Foreign exchange
 
(231
)

260

Other comprehensive income (loss)
 
66


(40
)
Balance – end of year
 
178

 
356

Less: current portion
 
(104
)

75

 
 
$
282

 
$
281

Net loss (gain) from risk management activities for the years ended December 31 were as follows:
 
 
2019


2018

 
2017

Net realized risk management loss (gain)
 
$
64


$
(99
)
 
$
(2
)
Net unrealized risk management loss (gain)
 
13


(35
)
 
37

 
 
$
77

 
$
(134
)
 
$
35

Schedule of Derivative Financial Instruments Outstanding to Manage Commodity Price Risk [Table Text Block]
At December 31, 2019, the Company had the following derivative financial instruments outstanding to manage its commodity price risk:
 
Remaining term
Volume
Weighted average price
Index
Natural Gas
 
 
 
 
 
 
 
  AECO basis swaps
Jan 2020
Mar 2020
140,000 MMbtu/d
 
US$0.93
NYMEX
  AECO fixed price swaps 
Apr 2020
Oct 2020
102,500 GJ/d
 
$1.51
AECO

Schedule of derivative financial instruments
At December 31, 2019 the Company had the following cross currency swap contracts outstanding:
 
Remaining term
Amount
Exchange
rate (US$/C$)

Interest
rate (US$)

Interest
rate (C$)

Cross currency
 
 
 
 
 
 
 
Swaps
Jan 2020
Nov 2021
US$500
1.022

3.45
%
3.96
%
 
Jan 2020
Mar 2038
US$550
1.170

6.25
%
5.76
%
Disclosure of financial instrument sensitivities
The following table summarizes the annualized sensitivities of the Company’s 2019 net earnings and other comprehensive income (loss) to changes in the fair value of financial instruments outstanding as at December 31, 2019, resulting from changes in the specified variable, with all other variables held constant. These sensitivities are prepared on a different basis than those sensitivities disclosed in the Company’s other continuous disclosure documents, are limited to the impact of changes in a specified variable applied to financial instruments only and do not represent the impact of a change in the variable on the operating results of the Company taken as a whole. Further, these sensitivities are theoretical, as changes in one variable may contribute to changes in another variable, which may magnify or counteract the sensitivities. In addition, changes in fair value generally cannot be extrapolated because the relationship of a change in an assumption to the change in fair value may not be linear.
 
2019
2018
 
 

Increase (decrease) to
net earnings

(Increase) decrease
to other comprehensive
loss

Increase (decrease) to
net earnings

Increase (decrease)
to other comprehensive
income

Commodity price risk
 
 
 
 
Increase NYMEX/AECO basis US$0.10 MMBtu
$
1

$

$

$

Decrease NYMEX/AECO basis US$0.10 MMBtu
$
(1
)
$

$

$

Increase AECO $0.10/Mcf (1)
$
(1
)
$

$
(1
)
$

Decrease AECO $0.10/Mcf (1)
$
1

$

$
1

$

Increase WCS differential US$1.00/bbl
$

$

$
(5
)
$

Decrease WCS differential US$1.00/bbl
$

$

$
5

$

Interest rate risk




 
 
Increase interest rate 1%
$
(48
)
$
(21
)
$
(33
)
$
(21
)
Decrease interest rate 1%
$
48

$
24

$
33

$
25

Foreign currency exchange rate risk




 
 
Weakening of the Canadian dollar by US$0.01
$
(103
)
$

$
(114
)
$

Strengthening of the Canadian dollar by US$0.01
$
100

$

$
113

$


(1)
Movements in AECO are based on the Company's contracted AECO fixed price swap volumes at December 31, 2019 and 2018.
Schedule of maturity dates for financial liabilities
Scheduled debt repayments are as follows:
Year
Repayment

2020
$
2,391

2021
$
1,552

2022
$
3,879

2023
$
3,894

2024
$
1,148

Thereafter
$
8,226

The maturity dates of the Company’s financial liabilities were as follows:
 
 
Less than
1 year

 
1 to less than
2 years

 
2 to less than
5 years

 
Thereafter

Accounts payable
 
$
816

 
$

 
$

 
$

Accrued liabilities
 
$
2,611

 
$

 
$

 
$

Long-term debt (1)
 
$
2,391

 
$
1,552

 
$
8,921

 
$
8,226

Other long-term liabilities (2)
 
$
370

 
$
196

 
$
436

 
$
1,014

Interest and other financing expense (3)
 
$
881


$
813


$
1,771


$
4,856

(1)
Long-term debt represents principal repayments only and does not reflect interest, original issue discounts and premiums or transaction costs.
(2)
Lease payments included within other long-term liabilities reflect principal payments only and are as follows; less than one year, $233 million; one to less than two years, $171 million; two to less than five years, $391 million; and thereafter $1,014 million.
(3)
Includes interest and other financing expense on long-term debt and other long-term liabilities. Payments were estimated based upon applicable interest and foreign exchange rates at December 31, 2019.